Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC.

Burns TF, Ammakkanavar NR, Hollebecque A, Lee DH, Koyama T, Cassier PA, Italiano A, Han JY, Singhal N, Takeuchi S, Heist RS, Deming D, Spira A, Chu Q, Sacher A, Fujiwara Y, Chisamore MJ, You AX, McNeely SC, Fink A, Chen A, Oxnard GR, Willard MD, Murciano-Goroff YR, Dragnev KH

Open source

DOI: 10.1016/j.jtho.2025.11.018
Published: 2026 Apr
Container: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtho.2025.11.018,
  title = {Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC.},
  author = {Burns TF and Ammakkanavar NR and Hollebecque A and Lee DH and Koyama T and Cassier PA and Italiano A and Han JY and Singhal N and Takeuchi S and Heist RS and Deming D and Spira A and Chu Q and Sacher A and Fujiwara Y and Chisamore MJ and You AX and McNeely SC and Fink A and Chen A and Oxnard GR and Willard MD and Murciano-Goroff YR and Dragnev KH},
  year = {2026},
  journal = {Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  doi = {10.1016/j.jtho.2025.11.018},
  url = {https://doi.org/10.1016/j.jtho.2025.11.018}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC.
AU  - Burns TF
AU  - Ammakkanavar NR
AU  - Hollebecque A
AU  - Lee DH
AU  - Koyama T
AU  - Cassier PA
AU  - Italiano A
AU  - Han JY
AU  - Singhal N
AU  - Takeuchi S
AU  - Heist RS
AU  - Deming D
AU  - Spira A
AU  - Chu Q
AU  - Sacher A
AU  - Fujiwara Y
AU  - Chisamore MJ
AU  - You AX
AU  - McNeely SC
AU  - Fink A
AU  - Chen A
AU  - Oxnard GR
AU  - Willard MD
AU  - Murciano-Goroff YR
AU  - Dragnev KH
PY  - 2026
JO  - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
DO  - 10.1016/j.jtho.2025.11.018
UR  - https://doi.org/10.1016/j.jtho.2025.11.018
ER  -

APA

TF, B., NR, A., A, H., DH, L., T, K., PA, C., A, I., JY, H., N, S., S, T., RS, H., D, D., A, S., Q, C., A, S., Y, F., MJ, C., AX, Y., SC, M., A, F., A, C., GR, O., MD, W., YR, M., & KH, D. (2026). Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1016/j.jtho.2025.11.018

Source records

pubmed · retrieved 2026-09-26T11:05:58.702Z